$NEO
NEOGENOMICS INC

2017 Q1 Form 10-Q Financial Statement

#000156459017009543 Filed on May 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1 2015 Q4
Revenue $57.43M $59.70M $27.28M
YoY Change -3.81% 159.29% 9.12%
Cost Of Revenue $34.48M $32.53M $15.10M
YoY Change 5.99% 141.29% 11.85%
Gross Profit $22.95M $27.17M $12.23M
YoY Change -15.55% 184.71% 6.59%
Gross Profit Margin 39.96% 45.51% 44.82%
Selling, General & Admin $22.67M $23.81M $15.60M
YoY Change -4.78% 152.28% 60.82%
% of Gross Profit 98.77% 87.61% 127.58%
Research & Development $862.0K $1.446M $1.900M
YoY Change -40.39% 116.14% 375.0%
% of Gross Profit 3.76% 5.32% 15.54%
Depreciation & Amortization $3.979M $3.585M $1.890M
YoY Change 10.99% 126.04% 25.17%
% of Gross Profit 17.34% 13.19% 15.46%
Operating Expenses $23.53M $25.25M $17.40M
YoY Change -6.82% 149.89% 70.59%
Operating Profit -$580.0K $1.922M -$5.172M
YoY Change -130.18% -442.6% -506.6%
Interest Expense -$1.400M -$1.600M -$200.0K
YoY Change -12.5% 700.0% 0.0%
% of Operating Profit -83.25%
Other Income/Expense, Net $0.00 $2.000M
YoY Change
Pretax Income -$1.944M $329.0K -$3.400M
YoY Change -690.88% -143.52% -409.09%
Income Tax -$779.0K $174.0K -$2.000M
% Of Pretax Income 52.89%
Net Earnings -$1.165M $155.0K -$1.473M
YoY Change -851.61% -120.37% -240.69%
Net Earnings / Revenue -2.03% 0.26% -5.4%
Basic Earnings Per Share -$0.07 -$0.03
Diluted Earnings Per Share -$15.25K -$0.07 -$0.03
COMMON SHARES
Basic Shares Outstanding 78.65M shares 76.07M 60.86M
Diluted Shares Outstanding 78.65M shares 76.07M 60.86M

Balance Sheet

Concept 2017 Q1 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.00M $19.30M $23.40M
YoY Change -43.01% -38.14% -30.56%
Cash & Equivalents $11.04M $19.26M $23.42M
Short-Term Investments
Other Short-Term Assets $5.900M $6.500M $4.900M
YoY Change -9.23% 225.0% 145.0%
Inventory $6.000M $5.300M $5.108M
Prepaid Expenses
Receivables $61.70M $50.10M $48.94M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $84.58M $81.20M $99.03M
YoY Change 4.16% 41.63% 68.58%
LONG-TERM ASSETS
Property, Plant & Equipment $36.53M $33.60M $34.58M
YoY Change 8.72% 101.92% 129.26%
Goodwill $147.0M $147.0M
YoY Change 4919.43%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $167.0K $100.0K $129.0K
YoY Change 67.0% -28.06% -8.51%
Total Long-Term Assets $259.1M $265.6M $268.9M
YoY Change -2.46% 1014.7% 1102.5%
TOTAL ASSETS
Total Short-Term Assets $84.58M $81.20M $99.03M
Total Long-Term Assets $259.1M $265.6M $268.9M
Total Assets $343.6M $346.8M $368.0M
YoY Change -0.91% 327.31% 353.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.58M $15.30M $12.46M
YoY Change 34.5% 179.96% 98.03%
Accrued Expenses $10.50M $14.20M $13.60M
YoY Change -26.06% 208.7% 1025.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $8.900M
YoY Change
Long-Term Debt Due $3.750M $4.900M $600.0K
YoY Change -23.47% 28.95% -81.25%
Total Short-Term Liabilities $39.90M $34.30M $40.06M
YoY Change 16.33% 147.56% 173.94%
LONG-TERM LIABILITIES
Long-Term Debt $96.13M $56.40M $52.34M
YoY Change 70.45% 795.24% 887.47%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $96.13M $56.40M $73.12M
YoY Change 70.45% 689.03% 1102.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.90M $34.30M $40.06M
Total Long-Term Liabilities $96.13M $56.40M $73.12M
Total Liabilities $149.6M $106.7M $113.2M
YoY Change 40.21% 408.02% 446.71%
SHAREHOLDERS EQUITY
Retained Earnings -$21.94M
YoY Change 13.06%
Common Stock $231.5M
YoY Change 190.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $194.0M $240.2M $208.5M
YoY Change
Total Liabilities & Shareholders Equity $343.6M $346.8M $351.3M
YoY Change -0.92% 327.31% 333.12%

Cashflow Statement

Concept 2017 Q1 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income -$1.165M $155.0K -$1.473M
YoY Change -851.61% -120.37% -240.69%
Depreciation, Depletion And Amortization $3.979M $3.585M $1.890M
YoY Change 10.99% 126.04% 25.17%
Cash From Operating Activities -$1.686M $7.060M $2.120M
YoY Change -123.88% -993.67% 114.14%
INVESTING ACTIVITIES
Capital Expenditures $3.007M $1.001M -$540.0K
YoY Change 200.4% 18.88% -48.57%
Acquisitions
YoY Change
Other Investing Activities -$72.94M
YoY Change
Cash From Investing Activities -$3.007M -$1.000M -$73.48M
YoY Change 200.7% 19.05% 6898.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $505.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.204M -10.22M 60.80M
YoY Change -131.35% 1161.73% -10067.21%
NET CHANGE
Cash From Operating Activities -$1.686M 7.060M 2.120M
Cash From Investing Activities -$3.007M -1.000M -73.48M
Cash From Financing Activities $3.204M -10.22M 60.80M
Net Change In Cash -$1.489M -4.160M -10.56M
YoY Change -64.21% 70.49% 1476.12%
FREE CASH FLOW
Cash From Operating Activities -$1.686M $7.060M $2.120M
Capital Expenditures $3.007M $1.001M -$540.0K
Free Cash Flow -$4.693M $6.059M $2.660M
YoY Change -177.46% -471.26% 30.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75339000
CY2017Q1 us-gaap Goodwill
Goodwill
147019000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7697000
CY2017Q1 us-gaap Assets
Assets
343637000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
84581000
CY2017Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2766000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5857000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
20579000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4891000
CY2017Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
50000000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36531000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14644000
CY2017Q1 neo Pharma Services
PharmaServices
4986000
CY2016Q1 neo Pharma Services
PharmaServices
5082000
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
61676000
CY2016Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
59704000
CY2017Q1 us-gaap Cost Of Services
CostOfServices
34480000
CY2016Q1 us-gaap Cost Of Services
CostOfServices
32531000
CY2017Q1 us-gaap Gross Profit
GrossProfit
27196000
CY2016Q1 us-gaap Gross Profit
GrossProfit
27173000
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4997000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
13699000
CY2017Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6600000
CY2016Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6600000
CY2017Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78571158
CY2016Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
50000000
CY2016Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
3842000
CY2017Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
26860000
CY2017Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
69363000
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
21799000
CY2016Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
70259000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
14973000
CY2017Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
3837000
CY2017Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7583000
CY2017Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6600000
CY2016Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6600000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
862000
CY2017Q1 neo Clinical Testing Revenue
ClinicalTestingRevenue
56690000
CY2016Q1 neo Clinical Testing Revenue
ClinicalTestingRevenue
54622000
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79206945
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20801000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18005000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1446000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5648000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5800000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
27311000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
25251000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-115000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1922000
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1364000
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1593000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-825000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
155000
CY2017Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
894000
CY2016Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1840000
CY2017Q1 neo Amortization Of Preferred Stock Beneficial Conversion Feature
AmortizationOfPreferredStockBeneficialConversionFeature
1672000
CY2016Q1 neo Amortization Of Preferred Stock Beneficial Conversion Feature
AmortizationOfPreferredStockBeneficialConversionFeature
3727000
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3220000
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5412000
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.04
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.07
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.04
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.07
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78650000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76068000
CY2017Q1 us-gaap Depreciation
Depreciation
3979000
CY2016Q1 us-gaap Depreciation
Depreciation
3585000
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1725000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2026000
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
110000
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
182000
CY2017Q1 neo Share Based Compensation And Warrants
ShareBasedCompensationAndWarrants
1130000
CY2016Q1 neo Share Based Compensation And Warrants
ShareBasedCompensationAndWarrants
703000
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3783000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2663000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9989000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3809000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-283000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
225000
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1321000
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
401000
CY2017Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-738000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2180000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1686000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
7059000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3007000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1001000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3007000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1001000
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5006000
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10044000
CY2017Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1263000
CY2017Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
932000
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
97000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3204000
CY2016Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
7000
CY2016Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1372000
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
505000
CY2016Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1298000
CY2017Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
112000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-10222000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1489000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4164000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23420000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19256000
CY2017Q1 us-gaap Interest Paid
InterestPaid
1257000
CY2016Q1 us-gaap Interest Paid
InterestPaid
1416000
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
207000
CY2017Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1898000
CY2016Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
173000
CY2016Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
10471000
CY2017Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
113068000
CY2016Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
108371000
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q1 neo Percentage Of Consolidated Assets Net Revenues And Net Income Reported By Reportable Operating Segment
PercentageOfConsolidatedAssetsNetRevenuesAndNetIncomeReportedByReportableOperatingSegment
1.00
CY2016Q1 neo Percentage Of Consolidated Assets Net Revenues And Net Income Reported By Reportable Operating Segment
PercentageOfConsolidatedAssetsNetRevenuesAndNetIncomeReportedByReportableOperatingSegment
1.00
CY2017Q1 neo Number Of Primary Types Of Customers
NumberOfPrimaryTypesOfCustomers
2
CY2015Q4 us-gaap Goodwill
Goodwill
147019000
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84000000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8661000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6936000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5167000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5400000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5400000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8834000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5400000
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8733000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
102154000
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
97436000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5400000
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
48572000
CY2017Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
11105000
CY2017Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2080000
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2202000
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5625000
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2812000
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3750000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
13383000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2.86
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5400000
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5625000
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
84151000
CY2017Q1 neo Long Term Debt Including Current Maturities Due
LongTermDebtIncludingCurrentMaturitiesDue
101963000
CY2017Q1 us-gaap Long Term Debt
LongTermDebt
101963000
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
96133000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
5922000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
4362000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
2764000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
335000
CY2017Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
2278000
CY2017Q1 neo Capital Lease Obligations And Car Loans Current
CapitalLeaseObligationsAndCarLoansCurrent
5084000
CY2017Q1 neo Capital Lease Obligations And Car Loans Noncurrent
CapitalLeaseObligationsAndCarLoansNoncurrent
6021000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
8734000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
8112000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
8389000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
5960000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
84151000
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
115346000
CY2017Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
2278000
CY2017Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
83938000
CY2016Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
132720000
CY2017Q1 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
22262000
CY2016Q1 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
73016000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5136110
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
124998
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
210652
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42015
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5008441
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1202639
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.76
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.52
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.23
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.71
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.99
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.77
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M12D
CY2017Q1 neo Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
1130000
CY2016Q1 neo Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
787000

Files In Submission

Name View Source Status
0001564590-17-009543-index-headers.html Edgar Link pending
0001564590-17-009543-index.html Edgar Link pending
0001564590-17-009543.txt Edgar Link pending
0001564590-17-009543-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
neo-10q_20170331.htm Edgar Link pending
neo-20170331.xml Edgar Link completed
neo-20170331.xsd Edgar Link pending
neo-20170331_cal.xml Edgar Link unprocessable
neo-20170331_def.xml Edgar Link unprocessable
neo-20170331_lab.xml Edgar Link unprocessable
neo-20170331_pre.xml Edgar Link unprocessable
neo-ex311_8.htm Edgar Link pending
neo-ex312_6.htm Edgar Link pending
neo-ex321_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending